Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis-Reference-Cited by-同舟云学术

Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis

Published:2019-10 Issue: Volume:168 Page:48-56
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Razori María Valeria,Maidagan Paula M.,Ciriaci Nadia,Andermatten Romina B.,Barosso Ismael R.,Martín Pamela L.,Basiglio Cecilia L.,Sánchez Pozzi Enrique J.,Ruiz María Laura,Roma Marcelo G.^ORCID

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Consejo Nacional de Investigaciones Científicas y Técnicas

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference98 articles.

1. Inflammation-induced cholestasis;Trauner;J. Gastroenterol. Hepatol.,1999

2. The molecular pathogenesis of cholestasis in sepsis;Bhogal;Front. Biosci. (Elite Ed).,2013

3. The causes of obvious jaundice in South West Wales: perceptions versus reality;Whitehead;Gut,2001

4. Epidemiology of severe sepsis;Mayr;Virulence,2014

5. Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats;Sturm;J. Hepatol.,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tauroursodeoxycholate prevents estradiol 17β-d-glucuronide-induced cholestasis and endocytosis of canalicular transporters by switching off pro-cholestatic signaling pathways;Life Sciences;2024-09

2. A fungal P450 enzyme from Fusarium equiseti HG18 with 7β-hydroxylase activity in biosynthesis of ursodeoxycholic acid;The Journal of Steroid Biochemistry and Molecular Biology;2024-06

3. Tauroursodeoxycholate Prevents Estradiol 17β-D-Glucuronide-Induced Cholestasis and Endocytosis of Canalicular Transporters by Switching Off Pro-Cholestatic Signaling Pathways;2024

4. Bile Acids Promote Hepatic Biotransformation and Excretion of Aflatoxin B1 in Broiler Chickens;Toxins;2023-12-09

5. Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-22